New Jersey · 2026-2027 Regular Session · Bill

A 5534: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.

In committee Last action September 24, 2026: Introduced, Referred to Assembly Health Committee

Plain-language summary

A 5534 is a bill introduced in the New Jersey House on September 24, 2026. According to its official title, it concerns: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder. Primary sponsor: Anthony Verrelli (Democratic). Most recent recorded action (September 24, 2026): Introduced, Referred to Assembly Health Committee.

Sponsors

Primary sponsor: Anthony Verrelli (Democratic).